Katalyze AI launches Digityze AI on Snowflake AI Data Cloud, enabling GMP-ready intelligence for biomanufacturing

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

Katalyze AI, an advanced AI company revolutionizing the biomanufacturing process, recently announced the launch of Digityze AI, an AI-powered document intelligence platform built natively on the Snowflake AI Data Cloud. The platform transforms unstructured documents into structured, compliant data, fueling real-time analytics that streamline pharmaceutical production and accelerate time to market for life-saving drugs.

Katalyze AI is an OBIO® member and an alumnus of our Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence.

Arsheen Kaur
Previous

OBIO® Paves the Way for Companies to Succeed in Canada as a Stepping Stone to New Global Markets
Next

FluidAI secures a $2 Million Government of Canada investment to accelerate global commercialization of AI-driven post operative care technology